User Reviews (1)
Review of: SH2D1A, BioLegend, 690702 by Emma Hajaj, Hebrew University of Jerusalem
Antibody used in the dilution of 1:1000. It took some time to calibrate it in the beginning.
For more information see Hajaj et al. eLife 2020, “SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint”.
https://elifesciences.org/articles/52539
0 useful
0 not useful
Comments